ロード中...
Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment
The potency of cancer vaccines is often compromised by a variety of immunoinhibitory mechanisms, including stimulation of the programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) immune checkpoint pathway. Here, to overcome inhibition, we determined the potential of recombinant a...
保存先:
| 出版年: | Mol Ther Oncolytics |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Gene & Cell Therapy
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7878991/ https://ncbi.nlm.nih.gov/pubmed/33614918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.01.010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|